Evaluation of bile-acid concentration in cerebrospinal fluid

Evaluation of bile-acid concentration in cerebrospinal fluid - BaLi

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017291

Enrollment

Registered

2019-05-15

Start date

2019-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbilirubinemia R17.9

Interventions

Group 1: In patients with external fluid leakage (external ventricular drainage or lumbar drainage) and concomitant hyperbilirubinemia, a small amount of cerebrospinal fluid is removed and tandem mass

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Women and men • Age> 18 years • Patients in the operative intensive care unit of the Department of Anaesthesiology (0119) • External ventricular drainage or lumbar drainage

Exclusion criteria

Exclusion criteria: No informed consent

Design outcomes

Primary

Measure	Time frame
Concentration of Bile Acids in cerebrospinal fluid	—

Secondary

Measure	Time frame
Difference in concentration between serum and cerebrospinal fluid	—

Countries

Germany

Contacts

Public ContactLars-Olav Harnisch

Universitätsmedizin GöttingenKlinik für Anästhesiologie

lars-olav.harnisch@med.uni-goettingen.de05513963579

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026